Oral and maxillofacial surgeons are among the healthcare providers who administer and prescribe essential drugs, such as Propofol and IV saline solution, on a daily basis. Like their health professional colleagues, OMSs are often among the last to know when an essential drug will be in short supply or no longer available. In 2012, Congress enacted the Food and Drug Administration Safety and Innovation Act (FDASIA), which included provisions to address the growing number of drug shortages. The Food and Drug Administration (FDA) is tasked with carrying out the drug shortage-related provisions of the law, which include various studies and reports back to Congress regarding the causes of and ways to ameliorate drug shortages. Despite efforts by the federal government to address the issue, drug shortages still persist and the push to effectively address the issue remains a priority for AAOMS.
- Federal Comment Letters
Joint Comment Letter to the FDA Re: Proposed Rule to Require Prior Notification of by Manufacturers of a Drug Shortage
- January 03, 2014
Coalition Letter to Chairman and Ranking Member of Senate HELP Committee Re: Incorporation of Dental-Specific Drug Shortage Prevention Preferences in Final Version of Prescription Drug User Fee Act (PDUFA)
- June 15, 2012